STRO vs UPST · rev $62.0M vs P/E 74, rev $636.5M
Sutro Biopharma (STRO) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported UPST revenue for 2024-12-31 was $636.5M. Net income was -$128.6M. Revenue was up 23.9% from 2023-12-31 to 2024-12-31. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
STRO currently screens at market cap $470.8M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the STRO and UPST stock pages for the full models.
Not investment advice.